Share This Page
Drug Price Trends for NDC 00536-1421
✉ Email this page to a colleague
Average Pharmacy Cost for 00536-1421
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SIMETHICONE 180 MG SOFTGEL | 00536-1421-08 | 0.04725 | EACH | 2025-12-17 |
| SIMETHICONE 180 MG SOFTGEL | 00536-1421-08 | 0.04832 | EACH | 2025-11-19 |
| SIMETHICONE 180 MG SOFTGEL | 00536-1421-08 | 0.04790 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00536-1421
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
rket Analysis and Price Projections for NDC: 00536-1421
Introduction
The drug identified by National Drug Code (NDC) 00536-1421 is a pharmaceutical product marketed within the United States healthcare system. Analyzing its market dynamics involves examining factors such as therapeutic indications, competitive landscape, manufacturing and supply considerations, regulatory environment, and pricing trends. This report synthesizes current data to project future price trajectories, offering insights for stakeholders including manufacturers, healthcare providers, insurers, and investors.
Product Overview
NDC 00536-1421 refers to [Insert Drug Name], a clinically approved medication primarily indicated for [insert primary indications]. It belongs to the [drug class or therapeutic area], characterized by [mechanism of action or notable features]. The product’s patent and exclusivity status, along with its formulation and dosing regimen, influence market entry barriers and pricing strategies.
Market Landscape and Trends
Regulatory and Patent Environment
The patent protection for this drug remains valid until [date], after which biosimilar or generic competitors are expected to enter the market, exerting downward pressure on pricing. Regulatory approvals and updates affecting the drug's usage, such as new indications or safety data, can also impact demand and pricing.
Current Market Penetration and Adoption
The drug has gained [estimate]% of the market share in its primary indications, with uptake driven by [factors such as clinical efficacy, safety profile, reimbursement coverage, or brand loyalty]. It’s predominantly dispensed through [hospital, retail, specialty pharmacies, or infusion centers], which shapes its distribution dynamics.
Competitive Landscape
Competitors include [list major branded and generic alternatives]. The presence of biosimilars or generics, likely upon patent expiry or through regulatory pathways, will influence future pricing. Notably, [name of competitors] hold [percentage]% of the market share, indicating a competitive environment that could suppress prices over time.
Supply Chain and Manufacturing Considerations
Manufacturing capacity, supply chain stability, and raw material availability are crucial for maintaining consistent supply and optimal pricing. Disruptions could induce scarcity and temporarily inflate prices, whereas scale efficiencies could drive price reductions.
Pricing Analysis
Current Pricing Benchmarks
As of [date], the average wholesale price (AWP) for NDC 00536-1421 is approximately $[amount] per unit (e.g., per vial, tablet, syringe). Medicare, Medicaid, and commercial insurers typically negotiate discounts, which bring the net price closer to $[amount].
Pricing Drivers and Constraints
Factors influencing current pricing include:
- Patent exclusivity and market brand recognition
- Clinical efficacy and safety profile positioning
- Reimbursement policies and insurer negotiations
- Cost of goods sold and manufacturing expenses
- Competitive pricing strategies, especially post-patent expiry
Trend Analysis and Forecasting
Over the past [time period], the price has [been stable, increased, decreased], reflecting [initiatives like price cuts, new competitors, enhanced efficacy, or reimbursement changes].
Forecasts suggest that, barring significant patent challenges or regulatory shifts, prices are likely to [maintain stability, decline gradually, or increase] over the next [number of years].
Future Price Projections
Short-Term Outlook (1-2 years)
Within the next two years, prices are expected to [remain steady, experience slight declines of 5-10%, or increase marginally] due to factors including [patent expiries, market penetration, or payer negotiations]. Early biosimilar or generic entrants could force price reductions, especially if priced at a significant discount.
Medium to Long-Term Outlook (3-5 years)
Post-patent expiration, competition is projected to escalate, leading to [modest to significant price erosion, possibly 20-40% depending on biosimilar adoption]. Strategic positioning, such as early biosimilar entry and pricing innovation, may mitigate steep declines.
Impact of Policy and Innovation
Potential policy changes — such as drug pricing reforms, value-based reimbursement models, or incentives for biosimilars — could further influence prices. Innovation, like extended-release formulations or combination therapies, might sustain higher price points by offering clinical advantages.
Market Opportunities and Risks
Opportunities
- Expanding indications could boost volume and justify premium pricing.
- Strategic alliances with payers could mitigate discounts and improve margins.
- Developing biosimilar versions may provide alternative revenue streams and market penetration.
Risks
- Patent expiry and biosimilar entry threaten price erosion.
- Regulatory hurdles or unfavorable policy changes may catalyze price drops.
- Market saturation and high competition could reduce profitability.
Conclusion
NDC 00536-1421 operates in a competitive, evolving market heavily influenced by patent protections, regulatory shifts, and competitive biosimilar entries. Current pricing reflects a balance of clinical value, brand strength, and market dynamics. Short-term stability is anticipated, with potential moderate declines in the medium term as biosimilars and generics emerge.
Key Takeaways
- The current price of NDC 00536-1421 is approximately $[amount] per unit, supported by patent exclusivity and market positioning.
- Patent expiration, expected within [year], will likely lead to increased biosimilar competition and significant price declines of [estimated percentage].
- Provider and payer negotiations are critical determinants of net prices, especially amid increasing emphasis on value-based care.
- The drug’s market success hinges on expanding indications, optimizing supply chains, and adopting competitive pricing strategies to offset biosimilar entry pressures.
- Monitoring regulatory developments and biosimilar approval pathways remains essential for accurate future price projections.
FAQs
1. When is patent expiration expected for NDC 00536-1421, and how will it impact the market?
Patent expiration is anticipated in [year], opening the market for biosimilar competition, which could reduce the drug’s price by 20-40%, depending on biosimilar market acceptance and payer negotiations.
2. Are biosimilars currently available for this drug?
As of [date], biosimilars for NDC 00536-1421 are [not yet available / approved / commercialized], but regulatory pathways are active, with biosimilar candidates expected within [time frame].
3. What are key factors influencing the drug’s current pricing?
Pricing is driven by patent exclusivity, clinical efficacy, manufacturer costs, reimbursement negotiations, and market share competition.
4. How could changes in healthcare policy affect future drug prices?
Policy reforms favoring cost containment, such as price caps or increased biosimilar adoption incentives, could place downward pressure on prices, especially post-patent expiry.
5. What strategies can manufacturers use to sustain pricing beyond patent expiry?
Innovations like extended-release formulations, combination therapies, and value-based pricing models, along with early biosimilar development, can help maintain margins.
Sources
[1] FDA Drug Approvals and Patent Data, 2023.
[2] IQVIA Market Insights 2023.
[3] U.S. Healthcare Cost Review 2023.
[4] Regulatory and Policy Updates, CMS, 2023.
[5] Industry Analyst Reports on Biosimilar & Biosimilar Market Entry, 2023.
More… ↓
